Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development
-
CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing
-
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
-
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery
-
CDT Notes Sarborg Publication of PRISM Framework Expanding AI
-
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
-
Sarborg Curates Rare Disease Signature Database to Expand AI Signature Intelligence Platform
-
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
-
CDT Positions for Transformational Growth
-
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals